FXR modulation may have multiple implications in the treatment of NASH since, besides bile acid (BA) synthesis, this receptor is involved in glucose and lipid metabolism, and in the regulation of inflammation [45]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.